News and Trends 18 Sep 2017
British Rapid Action Allergy Vaccine Gets Approval for Phase II Trial
Allergy Therapeutics’ vaccine against hayfever has received approval to begin a trial to determine its optimal dose. Allergy Therapeutics will begin a Phase II trial of its PQ Grass vaccine…